{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,12,14]],"date-time":"2024-12-14T09:20:48Z","timestamp":1734168048153,"version":"3.30.2"},"reference-count":15,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Respiratory Medicine and Research"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.resmer.2024.101138","type":"journal-article","created":{"date-parts":[[2024,8,30]],"date-time":"2024-08-30T21:04:04Z","timestamp":1725051844000},"page":"101138","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Sarcoid-like reaction related to ALK-ROS inhibitors in lung cancer patients"],"prefix":"10.1016","volume":"86","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-6000-2903","authenticated-orcid":false,"given":"Clara","family":"Morin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Villeneuve","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emma","family":"Norkowski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lise","family":"Rosencher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacques","family":"Cadranel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julien","family":"Mazi\u00e8res","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.resmer.2024.101138_bib0001","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/s43018-023-00515-0","article-title":"ALK-positive lung cancer: a moving target","volume":"4","author":"Schneider","year":"2023","journal-title":"Nat Cancer"},{"key":"10.1016\/j.resmer.2024.101138_bib0002","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1056\/NEJMoa2027187","article-title":"First-line lorlatinib or crizotinib in advanced ALK -positive lung cancer","volume":"383","author":"Shaw","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.resmer.2024.101138_bib0003","doi-asserted-by":"crossref","DOI":"10.3892\/or.2020.7851","article-title":"Safety and efficacy of anaplastic lymphoma kinase tyrosine kinase inhibitors in non\u2011small cell lung cancer (Review)","author":"Wang","year":"2020","journal-title":"Oncol Rep"},{"key":"10.1016\/j.resmer.2024.101138_bib0004","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1634\/theoncologist.2018-0380","article-title":"Clinical management of adverse events associated with Lorlatinib","volume":"24","author":"Bauer","year":"2019","journal-title":"The Oncologist"},{"key":"10.1016\/j.resmer.2024.101138_bib0005","doi-asserted-by":"crossref","first-page":"e151","DOI":"10.1016\/j.cllc.2017.10.008","article-title":"Lung toxicity in non\u2013small-cell lung cancer patients exposed to ALK inhibitors: report of a peculiar case and systematic review of the literature","volume":"19","author":"Pellegrino","year":"2018","journal-title":"Clin Lung Cancer"},{"key":"10.1016\/j.resmer.2024.101138_bib0006","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1097\/MCP.0000000000000800","article-title":"Drug-induced sarcoidosis-like reactions","volume":"27","author":"Miedema","year":"2021","journal-title":"Curr Opin Pulm Med"},{"key":"10.1016\/j.resmer.2024.101138_bib0007","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/j.chest.2018.03.056","article-title":"Drug-induced sarcoidosis-like reactions","volume":"154","author":"Chopra","year":"2018","journal-title":"Chest"},{"key":"10.1016\/j.resmer.2024.101138_bib0008","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.ejca.2020.02.024","article-title":"Drug-induced sarcoidosis-like reaction in adjuvant immunotherapy: increased rate and mimicker of metastasis","volume":"131","author":"Chorti","year":"2020","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.resmer.2024.101138_bib0009","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1111\/joim.12991","article-title":"Drug-induced sarcoidosis: an overview of the WHO pharmacovigilance database","volume":"288","author":"Cohen Aubart","year":"2020","journal-title":"J Intern Med"},{"key":"10.1016\/j.resmer.2024.101138_bib0010","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1007\/s10637-022-01270-2","article-title":"Pulmonary granulomatous inflammation after ceritinib treatment in advanced ALK-rearranged pulmonary adenocarcinoma","volume":"40","author":"Liao","year":"2022","journal-title":"Invest New Drugs"},{"key":"10.1016\/j.resmer.2024.101138_bib0011","doi-asserted-by":"crossref","first-page":"3140","DOI":"10.12998\/wjcc.v9.i13.3140","article-title":"Sarcoidosis mimicking metastases in an echinoderm microtubule-associated protein-like 4 anaplastic lymphoma kinase positive non-small-lung cancer patient: a case report","volume":"9","author":"Chen","year":"2021","journal-title":"World J Clin Cases"},{"key":"10.1016\/j.resmer.2024.101138_bib0012","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1111\/cup.13911","article-title":"Cutaneous sarcoid-like drug reaction caused by an anaplastic lymphoma kinase inhibitor","volume":"48","author":"Gleue","year":"2021","journal-title":"J Cutan Pathol"},{"key":"10.1016\/j.resmer.2024.101138_bib0013","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1007\/s10637-018-0652-3","article-title":"Sarcoid-like reaction mimicking disease progression in an ALK-positive lung cancer patient receiving lorlatinib","volume":"37","author":"Facchinetti","year":"2019","journal-title":"Invest New Drugs"},{"key":"10.1016\/j.resmer.2024.101138_bib0014","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s40425-018-0323-0","article-title":"Granulomatous\/sarcoid-like lesions associated with checkpoint inhibitors: a marker of therapy response in a subset of melanoma patients","volume":"6","author":"Tetzlaff","year":"2018","journal-title":"J Immunother Cancer"},{"key":"10.1016\/j.resmer.2024.101138_bib0015","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2022.884386","article-title":"Sarcoid-like reaction in patients with malignant tumors: long-term clinical course and outcomes","volume":"9","author":"Huh","year":"2022","journal-title":"Front Med"}],"container-title":["Respiratory Medicine and Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590041224000540?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590041224000540?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,14]],"date-time":"2024-12-14T08:04:55Z","timestamp":1734163495000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2590041224000540"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":15,"alternative-id":["S2590041224000540"],"URL":"https:\/\/doi.org\/10.1016\/j.resmer.2024.101138","relation":{},"ISSN":["2590-0412"],"issn-type":[{"type":"print","value":"2590-0412"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sarcoid-like reaction related to ALK-ROS inhibitors in lung cancer patients","name":"articletitle","label":"Article Title"},{"value":"Respiratory Medicine and Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.resmer.2024.101138","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 SPLF and Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"101138"}}